Hotaling Investment Management, LLC Abb Vie Inc. Transaction History

Hotaling Investment Management, LLC

$221 Million
Q4 2022

A detailed history of Hotaling Investment Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Hotaling Investment Management, LLC holds 23,601 shares of ABBV stock, worth $4.16 Million. This represents 1.72% of its overall portfolio holdings.

Number of Shares

23,601

Previous 23,526 0.32%

Holding current value

$4.16 Million

Previous $3.16 Million 20.81%

% of portfolio

1.72%

Previous 1.51%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $10,373 - $12,440	75 Added 0.32%	23,601 $3.81 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $56,233 - $64,496	419 Added 1.81%	23,526 $3.16 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $149,592 - $190,181	1,087 Added 4.94%	23,107 $3.54 Million
Q1 2022 Apr 22, 2022	BUY	$131.98 - $163.75 $615,818 - $764,057	4,666 Added 26.89%	22,020 $3.57 Million
Q4 2021 Jan 24, 2022	SELL	$107.43 - $135.93 $2,793 - $3,534	-26 Reduced 0.15%	17,354 $2.35 Million
Q3 2021 Oct 21, 2021	BUY	$106.4 - $120.78 $36,601 - $41,548	344 Added 2.02%	17,380 $1.88 Million
Q2 2021 Aug 04, 2021	BUY	$105.21 - $117.21 $1.37 Million - $1.53 Million	13,067 Added 329.23%	17,036 $1.92 Million
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $10,230 - $11,262	-100 Reduced 2.46%	3,969 $429,000
Q4 2020 Jan 22, 2021	SELL	$80.49 - $108.67 $2,012 - $2,716	-25 Reduced 0.61%	4,069 $436,000
Q3 2020 Nov 04, 2020	SELL	$85.91 - $100.83 $634,445 - $744,629	-7,385 Reduced 64.33%	4,094 $359,000
Q2 2020 Jul 31, 2020	BUY	$73.37 - $98.18 $536,334 - $717,695	7,310 Added 175.34%	11,479 $1.13 Million
Q1 2020 Apr 08, 2020	SELL	$64.5 - $97.79 $6,127 - $9,290	-95 Reduced 2.23%	4,169 $318,000
Q4 2019 Jan 28, 2020	BUY	$72.13 - $90.25 $29,212 - $36,551	405 Added 10.49%	4,264 $378,000
Q3 2019 Oct 28, 2019	SELL	$62.98 - $75.72 $28,215 - $33,922	-448 Reduced 10.4%	3,859 $292,000
Q2 2019 Aug 08, 2019	BUY	$65.7 - $83.98 $328 - $419	5 Added 0.12%	4,307 $313,000
Q1 2019 May 01, 2019	SELL	$77.14 - $90.79 $25,379 - $29,869	-329 Reduced 7.1%	4,302 $347,000
Q4 2018 Jan 17, 2019	BUY	$77.85 - $96.01 $360,523 - $444,622	4,631 New	4,631 $427,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $312B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hotaling Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hotaling Investment Management, LLC with notifications on news.

Account

Hotaling Investment Management, LLC Abb Vie Inc. Transaction History